These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 2879055

  • 1. Cardiohemodynamic effects of nipradilol (K-351) in the dog: comparison with propranolol, nadolol and prazosin.
    Kawada M, Satoh K, Taira N.
    Jpn J Pharmacol; 1986 Sep; 42(1):9-18. PubMed ID: 2879055
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular effects of nipradilol, a beta-adrenoceptor blocker with vasodilating properties.
    Fujii M, Shirasawa Y, Kondo S, Sawanobori K, Nakamura M.
    Jpn Heart J; 1986 Mar; 27(2):233-50. PubMed ID: 2873263
    [Abstract] [Full Text] [Related]

  • 3. [Effects of nipradilol, a new beta-blocker, and its metabolite, denitro-nipradilol, on heart rate and AV conduction in anesthetized dogs].
    Nakao Y, Nakaya H, Kanno M.
    Nihon Yakurigaku Zasshi; 1986 Aug; 88(2):85-94. PubMed ID: 2876932
    [Abstract] [Full Text] [Related]

  • 4. Effects of perhexiline on hemodynamics in anesthetized open-chest dogs.
    Ono H, O'Hara N, Hashimoto K.
    Jpn Heart J; 1981 Nov; 22(6):951-8. PubMed ID: 7339008
    [Abstract] [Full Text] [Related]

  • 5. Long-term haemodynamic effects of a 4-week regimen of nipradilol, a new beta-blocker with nitrovasodilating properties, in patients with portal hypertension due to cirrhosis. A comparative study with propranolol.
    Aramaki T, Sekiyama T, Katsuta Y, Kurokawa H, Komeichi H, Tsutsui H, Terada H, Ohsuga M, Satomura K, Okumura H.
    J Hepatol; 1992 May; 15(1-2):48-53. PubMed ID: 1354676
    [Abstract] [Full Text] [Related]

  • 6. Hemodynamic effects of nipradilol, a new beta-adrenergic antagonist combined with a nitroxy base, in rats with intra- or extra-hepatic portal hypertension.
    Ohsuga M, Cailmail S, Lebrec D.
    J Hepatol; 1993 Feb; 17(2):236-40. PubMed ID: 8095275
    [Abstract] [Full Text] [Related]

  • 7. Venodilating action of nipradilol (K-351) in the pithed rat pretreated with dihydroergotamine.
    Shirasawa Y, Fujii M, Nakamura M.
    Jpn J Pharmacol; 1985 Sep; 39(1):77-82. PubMed ID: 2866266
    [Abstract] [Full Text] [Related]

  • 8. Adrenoceptor-blocking activity and cardiohemodynamic effects of carvedilol in animals.
    Kawada T, Ishibashi T, Nakazawa M, Satoh S, Imai S.
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):147-53. PubMed ID: 1696657
    [Abstract] [Full Text] [Related]

  • 9. Effects of nipradilol on myocardial ischaemia produced by coronary stenosis in dogs.
    Noguchi K, Sakanashi M.
    Br J Pharmacol; 1987 Jun; 91(2):411-9. PubMed ID: 2886171
    [Abstract] [Full Text] [Related]

  • 10. Alpha-blockade and vasodilatation induced by nipradilol, arotinolol and labetalol in pithed rats.
    Nakagawa Y, Nakahara H, Chin WP, Imai S.
    Jpn J Pharmacol; 1985 Dec; 39(4):481-5. PubMed ID: 2419612
    [Abstract] [Full Text] [Related]

  • 11. Effects of nipradilol on venous hemodynamics: evaluation with a Doppler blood flow method.
    Maekawa K, Saito D, Kobayashi H, Mizuo K, Obayashi N, Uchida S, Haraoka S.
    Acta Med Okayama; 1994 Apr; 48(2):87-91. PubMed ID: 8042538
    [Abstract] [Full Text] [Related]

  • 12. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
    Kawashima K, Watanabe TX, Sokabe H.
    Jpn J Pharmacol; 1984 Dec; 36(4):519-26. PubMed ID: 6151998
    [Abstract] [Full Text] [Related]

  • 13. Actions of nipradilol (K-351), a new alpha- and beta-adrenoceptor blocker, on the rabbit portal vein.
    Nanjo T, Kitamura K.
    Jpn J Pharmacol; 1984 Aug; 35(4):359-69. PubMed ID: 6150128
    [Abstract] [Full Text] [Related]

  • 14. Effects of nipradilol on alpha-adrenoceptor function in ocular arteries.
    Okamura T, Fujioka H, Ayajiki K.
    Pharmacology; 2002 May; 65(2):110-8. PubMed ID: 11937782
    [Abstract] [Full Text] [Related]

  • 15. Comparative effects of propranolol and nadolol on renal blood flow in normal rats and rats with congestive heart failure.
    Brenner BM, Duchin KL, Ichikawa I, Pfeffer J, Pfeffer M.
    Am Heart J; 1984 Oct; 108(4 Pt 2):1144-7. PubMed ID: 6148876
    [Abstract] [Full Text] [Related]

  • 16. Effects of equiblocking doses of nadolol and propranolol on left ventricular performance.
    Le Winter MM, Curtis GP, Engler RL, Shabetai R, Verba J.
    Clin Pharmacol Ther; 1979 Aug; 26(2):162-6. PubMed ID: 37012
    [Abstract] [Full Text] [Related]

  • 17. Effect of nipradilol on myocardial energy metabolism in the dog ischaemic heart.
    Hayase N, Chiba K, Ichihara K, Inagaki S, Abiko Y.
    J Pharm Pharmacol; 1990 Jun; 42(6):419-22. PubMed ID: 1979622
    [Abstract] [Full Text] [Related]

  • 18. Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.
    Patterson E, Lucchesi BR.
    Pharmacology; 1984 Jun; 28(3):121-9. PubMed ID: 6144114
    [Abstract] [Full Text] [Related]

  • 19. Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity.
    Beaulieu G, Grimes D, Muirhead C, Oshiro G.
    Can J Physiol Pharmacol; 1984 Jun; 62(6):610-6. PubMed ID: 6146394
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.